Federal Register Notice: FDA is making available a draft guidance for industry entitled Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format. The draft guidance is intended to help ensure that the labeling is clear, useful, informative, and to the extent possible, consistent in content and format. To download this guidance, click here. To view this notice, click here.